Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes

NCT06224803 is registered in ClinicalTrials.gov with Global Preventive Medicine Biotech Co., Ltd. as lead sponsor.

NCT NCT06224803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06224803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes
Lead sponsor
Global Preventive Medicine Biotech Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
August 26, 2020
Completion date
January 18, 2022
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes